DSNKY
Daiichi Sankyo Co., Ltd. ADROTCPK - Current
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • Apr. 7, 2014, 3:32 AM
    • Sun Pharmaceutical Industries has agreed to acquire fellow Indian company Ranbaxy Laboratories (RBXLY) for $3.2B in an all-stock deal that will create the world's fifth-largest generic-drug maker. Including the debt, the transaction is worth $4B.
    • The merger combines two firms that have had problems with quality issues. Ranbaxy, which is owned by Japan's Daiichi Sankyo (DSKYF), is banned from selling ingredients to the U.S., while Sun's Karkhadi facility is also not allowed to export products to the U.S. (PR)
    | Apr. 7, 2014, 3:32 AM | 1 Comment